Blue Cross Blue Shield of Massachusetts is trying a new way of paying hospitals and doctors. Instead of paying for every hospital visit and surgery, the insurance giant is offering a flat, annual fee per patient. Stacey Vanek-Smith reports.
A company called 23andMe is now offering a direct-to-consumer genetic testing service. For $999 it will give you a detailed analysis of your DNA. But might that be the very definition of too much information? Ashley Milne-Tyte reports.
Pennsylania's governor has reversed an effort to ban milk-container labels that tell consumers the milk comes from cows not treated with a growth hormone. Consumer groups are hailing his decision. Sarah Gardner reports.
The drug Vytorin has been a multibillion-dollar blockbuster -- although it hasn't exactly been the cholesterol buster it was supposed to be. Commentator and physician Dr. Stefan Kertesz says it's a cautionary tale about the process of approving new pharmaceuticals.